- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fonar pursues legal battle with MR Plus
Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S.
Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S. District Court for the southern district of New York also ordered a new trial, according to Fonar.
In December, a federal jury had awarded MR Plus $2.3 million, but the verdict was later overturned by the appeals court in January, which also reinstated Fonar's copyright-infringement and unfair-competition claims (SCAN 3/5/97).
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
